UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000020669
Receipt No. R000023855
Official scientific title of the study An open trial regarding the safety and efficacy of blonanserin for patients with gambling disorder
Date of disclosure of the study information 2016/01/21
Last modified on 2017/04/27 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study An open trial regarding the safety and efficacy of blonanserin for patients with gambling disorder
Title of the study (Brief title) Open trial of blonanserin for gambling disorder
Region
Japan

Condition
Condition Gambling disorder
Classification by specialty
Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine the safety and efficacy of blonanserin for patients with gambling disorder
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Overall severity of DIEPSS at 8 weeks
Key secondary outcomes The change of the scores in GSAS, PG-YBOCS, BIS-11, and CGI-C at 8 weeks

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Blonanserin, 2-12 mg/day, 8 weeks
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria 1. Gambling disorder as defined by DSM-5
2. Outpatients of Chiba University Hospital
3. 20<= age at consent < 65
4. 5>= SOGS score
Key exclusion criteria 1. Incompetent
2. Pregnant, nursing, or being expected as so
3. F2 or F0 by ICD-10
4. uncontrolled physical illness
5. taking antipsychotic drugs within 28 days before
6. taking prohibited with blonanserin
7. history of allergic reaction for blonanserin
8. history of malignant syndrome or tardive dyskinesia caused by antipsychotic drugs
9. participated other clinical trials within 3 month before
10. 15 >= MADRS
11. 15 >= YMRS
12. 3 >= overall severity of DIEPSS
13. history of suicide attempt within one years before
14. contraindicated by the doctor in charge
Target sample size 3

Research contact person
Name of lead principal investigator Akihiro Shiina
Organization Chiba University
Division name Department of psychiatry, Graduate school of medicine
Address Inohana 1-8-1, Chuoh-ku, Chiba-shi
TEL +81-42-222-7171
Email shiina-akihiro@faculty.chiba-u.jp

Public contact
Name of contact person Akihiro Shiina
Organization Chiba University
Division name Department of psychiatry, Graduate school of medicine
Address Inohana 1-8-1, Chuoh-ku, Chiba-shi
TEL +81-42-222-7171
Homepage URL
Email shiina-akihiro@faculty.chiba-u.jp

Sponsor
Institute Chiba University
Institute
Department

Funding Source
Organization Council for Addiction Behavior Studies
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs YES
Study ID_1 G27039
Org. issuing International ID_1 Chiba University Hospital Clinical Research Center
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 千葉大学医学部附属病院(千葉県)

Other administrative information
Date of disclosure of the study information
2016 Year 01 Month 21 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 12 Month 24 Day
Anticipated trial start date
2016 Year 01 Month 07 Day
Last follow-up date
2016 Year 12 Month 31 Day
Date of closure to data entry
2017 Year 03 Month 22 Day
Date trial data considered complete
2017 Year 03 Month 22 Day
Date analysis concluded
2017 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 01 Month 20 Day
Last modified on
2017 Year 04 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023855